Literature DB >> 14745254

[A case of sarcomatoid combined hepatocellular-cholangiocarcinoma].

Bong Ju Jeong1, Dong Hyo Hyun, Kyoung Wook Lee, Sung Tae Ryu, Jin-Woo Lee, Jung Il Lee, Seok Jeong, Don Hang Lee, Pum-Soo Kim, Hyung Gil Kim, Young Soo Kim, Jun Mee Kim.   

Abstract

Combined hepatocellular-cholangiocarcinoma (HCC-CC) with sarcomatoid features is an extremely rare primary liver cancer, of which only four cases have been reported. We report a case of sarcomatoid combined HCC-CC in a 60-year-old woman who complained of right upper quadrant pain and presented with a 7 cm mass in the S4 region of the liver in abdominal CT. Ultrasonography-guided needle biopsy diagnosed it as HCC, and left lobectomy of the liver followed. Microscopically, the tumor consisted of two portions: HCC portion showing trabecular pattern, which had partially sarcomatous area with spindle-shaped tumor cells, and CC portion with glandular pattern. Immunohistochemically, HCC portion reacted positively with alpha-fetoprotein while CC portion demonstrated positive reactivity with carcinoembryonic antigen and mucicarmine. Sarcomatoid cells reacted positively for cytokeratin. She died of tumor recurrence and hepatic failure 12 months after the operation. Combined HCC-CC has poor prognosis, and sarcomatoid HCC has high metastatic potential and poor prognosis compared with ordinary HCC.

Entities:  

Mesh:

Year:  2004        PMID: 14745254

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  3 in total

Review 1.  Combined hepatocholangiocarcinoma: case-series and review of literature.

Authors:  Vishal Bhagat; Milind Javle; Jihnhee Yu; Aarti Agrawal; John F Gibbs; Boris Kuvshinoff; Enriquetta Nava; Renuka Iyer
Journal:  Int J Gastrointest Cancer       Date:  2006

2.  Combined hepatocellular and cholangiocarcinoma with sarcomatoid transformation: radiologic-pathologic correlation of a case.

Authors:  Uei Pua; Su-Chong Low; Yu-Meng Tan; Kiat-Hon Lim
Journal:  Hepatol Int       Date:  2009-09-10       Impact factor: 6.047

Review 3.  Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.

Authors:  An-Qiang Wang; Yong-Chang Zheng; Juan Du; Cheng-Pei Zhu; Han-Chun Huang; Shan-Shan Wang; Liang-Cai Wu; Xue-Shuai Wan; Hao-Hai Zhang; Ruo-Yu Miao; Xin-Ting Sang; Hai-Tao Zhao
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.